November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Albert Koong: PFS of 10.3 month vs. 2.5 month in Pancreas Cancer patients with oligometastatic disease
Aug 9, 2024, 16:38

Albert Koong: PFS of 10.3 month vs. 2.5 month in Pancreas Cancer patients with oligometastatic disease

Albert Koong, Division Head and Chair of the Department of Radiation Oncology at MD Anderson Cancer Center, shared on X:

“Congrats Ethan Ludmir and Chad Tang! This MD Anderson Cancer Center P2 randomized study shows PFS of 10.3 mo vs. 2.5 mo in Pancreas Cancer patients with oligometastatic disease treated with metastasis-directed therapy+systematic treatments  vs. systematic treatments alone.”

Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial

Autors: Ethan B. Ludmir, Alexander D. Sherry, Bryan M. Fellman, Suyu Liu, Tharakeswara Bathala, Cara Haymaker, Marina N. Medina-Rosales, Alexandre Reuben, Emma B. Holliday, Grace L.Smith, Sonal S. Noticewala, SarahNicholas, Tracy R. Price, Rachael M. Martin-Paulpeter, Luis A. Perles, Sunyoung S. Lee, Michael S. Lee, Brandon G. Smaglo, Ryan W. Huey, Jason Willis, Dan Zhao, Lorenzo Cohen, Cullen M. Taniguchi, Eugene J. Koay, Matthew H.G. Katz, Robert A. Wolff, Prajnan Das, Shubham Pant, Albert C. Koong, Chad Tang

Albert Koong
Source: Albert Koong/X